ArticleJournal of ovarian research2018

P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.

Luiz Gustavo de Almeida Chuffa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.